Rates of e-prescribing access is higher among pharmacists than physicians, which is partly due to older physicians at the end of their career who find implementing the system cost prohibitive, explained Doug Hillblom, PharmD, president at Arena Healthcare, LLC.
Rates of e-prescribing access is higher among pharmacists than physicians, which is partly due to older physicians at the end of their career who find implementing the system cost prohibitive, explained Doug Hillblom, PharmD, President at Arena Healthcare, LLC.
Transcript
What is the current state of e-prescribing in the United States?
E-prescribing in general, approximately 75% of physician practices, 95% of pharmacies are actively engaged for e-prescribing transactions. What we see is that in the physicians it is a little lower and some of it has to do with age of physicians or the size of the practice. But in pharmacies, basically about 95%, very, very few are not accepting those today and even that number will be increasing in the future.
What barriers are preventing further adoption of e-prescribing?
From the physician point of view is cost. Putting in an electronic health record is, for many smaller groups or older physicians who are looking at the end of their career, it’s somewhat cost prohibitive. The new technology and getting used to it and understanding that, they tend to have a little more resistance to it.
From the pharmacy end, there are certain types of practices that feel that e-prescribing doesn’t have any business linked to them. I think about those and go, “hmm.” I know 1 from personal experience that didn’t do electronic prescriptions because there was 1 doctor in town and 1 pharmacy and they were in the same building. So they just didn’t see a business need to do it. But, you know, that’s the unique situation, not the norm.
Physician-wise, I have a lot of friends who are doing e-prescribing and find it to be quite helpful. There are components of e-prescribing that we don’t even talk about. We think about just the initiation of prescription. Things like refills, getting refills into their electronic health records and being able to authorize those is really actually also part of the e-prescribing system or environment.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More